Rock Springs Capital Management LP Madrigal Pharmaceuticals, Inc. Transaction History
Rock Springs Capital Management LP
- $2.51 Billion
- Q4 2024
A detailed history of Rock Springs Capital Management LP transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 265,212 shares of MDGL stock, worth $87 Million. This represents 3.27% of its overall portfolio holdings.
Number of Shares
265,212
Previous 263,062
0.82%
Holding current value
$87 Million
Previous $55.8 Million
46.59%
% of portfolio
3.27%
Previous 1.9%
Shares
26 transactions
Others Institutions Holding MDGL
# of Institutions
336Shares Held
22.2MCall Options Held
960KPut Options Held
940K-
Janus Henderson Group PLC London, X02.21MShares$724 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$670 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$665 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$654 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$647 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.61B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...